Merck and MPP Enter Into License Agreement for Investigational Oral Antiviral COVID-19 Medicine October 29, 2021 Auto Bot News 0 Merck’s agreement with the Medicines Patent Pool (MPP) aims to facilitate affordable global access for molnupiravir.
